Skip to content

Study · Measured the body's own peptide · 1983

1 result

Immunological studies of male homosexuals with the prodrome of the acquired immunodeficiency syndrome (AIDS).

Hersh EM, Reuben JM, Mansell PW, Rios A, Newell GR, Frank J, Goldstein AL

Advances in experimental medicine and biology1 Jan 1983Cited by 1 (Europe PMC)

PMID6606304 (opens in a new tab)DOI10.1007/978-1-4757-1410-4_24 (opens in a new tab)PepBankPUB-06606304
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In male homosexual patients with the prodrome of AIDS, virtually all had elevated serum thymosin alpha‑1.

    In plain wordsIn men with the prodrome of AIDS, nearly all had raised levels of the body's own thymosin alpha‑1 in blood.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseSerum thymosin alpha 1 level in prodrome of AIDS
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Virtually all patients showed elevated serum thymosin alpha 1 levels and elevated serum lysozyme levels.
    1 context sentence
    Summary · context
    Homosexual patients who mainly had the prodrome of the syndrome of opportunistic infection and Kaposi's sarcoma were studied immunologically.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.